Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Sanjiv J. Shah, Brian Lee Claggett, Pardeep S. Jhund, John W. Ostrominski et al.
Journal
Diabetes Care
Topics
Heart Failure Treatment and Management
article
Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Sanjiv J. Shah, Brian Lee Claggett, Pardeep S. Jhund, John W. Ostrominski, John J.V. McMurray, Alasdair Henderson, Katja Rohwedder, Patrick Schloemer, Meike Brinker, Michele Senni, Muthiah Vaduganathan, Carolyn S.P. Lam, Henri Lu, Bertram Pitt, Adriaan A. Voors, Scott D Solomon, Akshay S. Desai, Faïez Zannad
article en
Abstract
No abstract available for this paper.
Publication Tag
Diabetes CareVol. 49(2)
Institutions
Northwestern University (US), Brigham and Women's Hospital (US), University Medical Center Groningen (NL), Inserm (FR), University of Michigan (US), British Heart Foundation (GB), Ospedale Papa Giovanni XXIII (IT), National University Heart Centre Singapore (SG), Michigan Medicine (US), National Heart Centre Singapore (SG), Bayer (Germany) (DE), Université de Lorraine (FR), University of Lausanne (CH)
Funders
American Heart Association, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, Sanofi, Brigham and Women's Hospital, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Analog Devices, Edwards Lifesciences, Medpace, Boston Scientific Corporation, Regeneron Pharmaceuticals, Ionis Pharmaceuticals, Acceleron, Cytokinetics, Sarepta Therapeutics, Prothena, Fresenius Medical Care North America, MyoKardia, Verily Life Sciences, Impulse Dynamics, Moderna, British Heart Foundation, University of Glasgow, Daiichi-Sankyo, Novo Nordisk, Idorsia Pharmaceuticals, Intas Pharmaceuticals, Esperion Therapeutics, National Institutes of Health, Sanofi Pasteur, American Regent, Respicardia, Medical Research Council, National Medical Research Council, Relypsa, National Heart, Lung, and Blood Institute